GlassScriptPhysician profile
Sajish Eapen Jacob
NPI 1164653853
$7,477.48
in general payments reported to CMS, 2019-2025
49 companies · $3,424 in 2025
The $3,424 reported for 2025 was more than what 81% of Clinical Neurophysiology providers received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $173 · 2021: $169 · 2022: $93.41 · 2023: $138 · 2024: $2,463 · 2025: $3,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,914 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,913.81 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $963.30 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $647.64 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Pfizer INC. | $394.88 | 2024-2025 | |
| Biogen, INC. | $393.64 | 2019-2025 | Leqembi, Skyclarys, Tysabri |
| Genentech USA, INC. | $361.40 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Sk Life Science, INC. | $344.68 | 2023-2025 | |
| Lilly USA, LLC | $332.41 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Eisai INC. | $330.79 | 2019-2025 | |
| Ucb, INC. | $305.16 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Emd Serono, INC. | $302.63 | 2019 | |
| Lundbeck LLC | $268.68 | 2019-2025 | Vyepti, Rexulti |
| Amgen INC. | $256.50 | 2019-2025 | Uplizna |
| Novartis Pharmaceuticals Corporation | $207.49 | 2019-2025 | |
| Grifols USA, LLC | $192.81 | 2019-2025 | Gamunex-C |
| Neurelis, INC. | $170.02 | 2024-2025 | Valtoco |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $161.08 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $143.52 | 2019-2020 | |
| Genzyme Corporation | $128.96 | 2024 | |
| Acadia Pharmaceuticals INC | $119.91 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $97.32 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Alnylam Pharmaceuticals INC. | $89.34 | 2024-2025 | Givlaari, Onpattro |
| Ge Healthcare | $88.15 | 2019-2024 | |
| Axsome Therapeutics, INC. | $81.72 | 2025 | Symbravo |
| Amneal Pharmaceuticals LLC | $78.10 | 2024-2025 | Crexont, Rytary |
| Abbott Laboratories | $76.99 | 2024-2025 | Infinity, Proclaim |
| Celgene Corporation | $73.05 | 2024-2025 | Zeposia |
| Vanda Pharmaceuticals INC. | $68.38 | 2025 | Ponvory |
| Neurocrine Biosciences, INC. | $64.41 | 2023-2024 | Ingrezza |
| Acorda Therapeutics, INC | $62.42 | 2019-2023 | Inbrija |
| Kyowa Kirin, INC. | $57.90 | 2024 | Nourianz |
| Alexion Pharmaceuticals, INC. | $52.05 | 2019-2024 | Ultomiris |
| Allergan, INC. | $50.00 | 2020 | |
| Boston Scientific Corporation | $49.95 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Takeda Pharmaceuticals U.S.A., INC. | $48.31 | 2024-2025 | Hyqvia |
| Tg Therapeutics, INC. | $48.08 | 2025 | |
| Azurity Pharmaceuticals, INC. | $41.19 | 2025 | |
| Springworks Therapeutics, INC. | $40.57 | 2025 | Gomekli |
| Avanir Pharmaceuticals, INC. | $37.72 | 2019 | |
| Tonix Medicines, INC. | $37.28 | 2025 | Zembrace Symtouch |
| Janssen Biotech, INC. | $37.08 | 2025 | |
| Sumitomo Pharma America, INC. | $32.76 | 2023-2024 | Aptiom |
| Tanabe Pharma America, INC. | $21.80 | 2025 | Radicava |
| Ani Pharmaceuticals, INC. | $20.34 | 2024 | Purified Cortrophin Gel |
| Ns Pharma, INC. | $20.03 | 2024 | Viltepso |
| Xeris Pharmaceuticals, INC. | $16.83 | 2025 | Keveyis |
| Currax Pharmaceuticals LLC | $16.68 | 2024 | Onzetra Xsail |
| Otsuka America Pharmaceutical, INC. | $16.08 | 2025 | Rexulti |
| Promius Pharma LLC | $13.77 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sajish Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.